Skip to content

BEAM

Beam Therapeutics Inc.

Key figures

MetricLast 12 months5-year CAGR
Revenue$147M+466.3%
Operating income−$393M—
Net income−$108M—
EPS−$1.01—
Free cash flow−$398M—